Delivery Order SPE2DR25D1109-SPE2DR26FFG6A
- Not listed
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Qualipita 60 mg tablets (30-count units) with a ceiling value of $11,073.97 and an ultimate completion date of October 22, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement designated SPE2DX and...
- The Defense Logistics Agency awarded a delivery order valued at $10,507.55 to AmerisourceBergen Drug Corp for Qualipita 60 mg tablets (30-count) on May 22, 2025, with completion scheduled for May 23, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a direct fulfillment of pharmaceutical supply needs for federal medical procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed...
- The Defense Logistics Agency awarded a $16,035.05 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Qualipita 60 mg tablets (30-count packages). This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. The pharmaceutical will be supplied from the contractor's facility in...
- The Defense Logistics Agency awarded a $2,875.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Qualipita 60 mg tablets (30-count units) on May 23, 2025, with an ultimate completion date of May 27, 2025. This non-set-aside contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,372.53 to AmerisourceBergen Drug Corp for the supply of Qualipita 60 mg tablets (30-count units) on November 5, 2025, with an ultimate completion date of November 6, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Qualipita 60 mg tablets in a 30-count configuration. This firm fixed-price delivery order, valued at $21,802.28, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, which carries a $999,999,999.00 ceiling and extends through December 2026. The award was made without a set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Qualipita 60 mg tablets in a quantity of 30s, with a ceiling value of $2,022.06 under firm fixed price terms. This is a non-set-aside contract with an ultimate completion date of November 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 1, 2025, for the supply of Qualiptа 60 mg tablets (30-count units) under a firm fixed price contract with a ceiling value of $3,728.78 and an ultimate completion date of April 2, 2025. This non-competitive delivery order represents a single pharmaceutical supply transaction executed through the company's existing contract vehicle with DLA. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Qualipta 60 mg tablets (30-count units) with a ceiling value of $1,976.31. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 13, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Qualipita 60 mg tablets (30-count) under a firm fixed price contract. The order, valued at $13,271.90, was competitively awarded without set-aside provisions and carries an ultimate completion date of October 21, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFG6ADelivery Order
The Defense Logistics Agency awarded a $5,814.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Qualipita 60 mg tablets (30-count packages). This non-set-aside delivery order is scheduled for ultimate completion on November 18, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, leverages its comprehensive IDC vehicle to supply a diverse portfolio of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company's federal contract awards demonstrate extensive capability in delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order exemplifies AmerisourceBergen's ongoing role in fulfilling DLA's pharmaceutical supply requirements for defense healthcare operations worldwide, supporting the Defense Health Agency and other government healthcare systems through the flexible and competitive IDC framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 11/17/25 |